Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04023435 · ClinicalTrials.gov registry record · NA
Pain Neuroscience Education for Depression
A NA study, sponsored by St. Ambrose University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04023435: Completed NA study, sponsored by St. Ambrose University.
NCT04023435 is a NA study that has completed, run by St. Ambrose University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04023435, a NA study, has completed, sponsored by St. Ambrose University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will look at the effects of Pain Neuroscience Education on a Depression outcome tool in patients with chronic low back pain.
Primary Outcome
Numeric Pain Rating Scale for Back Pain (0 = no pain and 10 = worst pain). The minimal detectable change (MDC) for the NPRS for low back pain is reported to be 2.0.
Interventions
- OTHER PNE edcuation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2019-11-05 |
| Phase | NA |
What the finished NCT04023435 record still lists
NCT04023435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which PNE edcuation is the first listed.
NCT04023435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04023435 about?
NCT04023435 is a clinical study titled "Pain Neuroscience Education for Depression". This study will look at the effects of Pain Neuroscience Education on a Depression outcome tool in patients with chronic low back pain.
What is the current status of trial NCT04023435?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-06-01. Estimated completion is 2019-11-05.
What interventions are being tested in trial NCT04023435?
The interventions under investigation include: PNE edcuation (OTHER).
Who is sponsoring clinical trial NCT04023435?
This trial is sponsored by St. Ambrose University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04023435's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI